Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride reduce semen quality, with dutasteride having a stronger negative effect.

Treating hematospermia can improve sexual function and reduce anxiety.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

The protein STAT3 slows down cell growth by blocking the FST gene, which affects hair development in sheep.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Finasteride exposure in pregnancy causes genital abnormalities in male rats.

Stopping finasteride improves sperm quality but not semen volume in young men.

Men using steroids or finasteride to look more attractive may harm their fertility and sexual function, creating a paradox where they seem fit but may be less able to reproduce.

Most hair follicle stem cells do not protect their DNA by dividing it unevenly.

A short male anogenital distance may indicate incomplete masculinization due to disrupted androgen action.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Chemotherapy for male germ cell tumors often leads to hypogonadism and related symptoms.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

Inhibiting connective tissue sheath contraction may improve hair growth in male pattern baldness.

Finasteride reduces blood vessel formation in seminal vesicles.

Finasteride may cause male infertility, stopping it can help.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

A 14-year-old girl with no menstrual period was diagnosed with Swyer Syndrome and treated for a related cancer risk.

A new gene mutation causes complete androgen insensitivity in a 16-year-old with a female appearance.

Trypsin slows hair growth and affects color by causing cell death in hair follicles.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

New treatments for male hypogonadism are effective and should be personalized.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Hedgehog signaling is crucial for mammary gland development over hair follicles.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.